Ruoff W L, Diamond G L, Velazquez S F, Stiteler W M, Gefell D J
Syracuse Research Corporation, New York 13210.
Regul Toxicol Pharmacol. 1994 Oct;20(2):139-60. doi: 10.1006/rtph.1994.1066.
Published studies in which rats were exposed to CdCl2 in standard chow or drinking water were analyzed to compare the relative bioavailability of cadmium from the two media. Relative bioavailability was assessed from estimates of the rate of accumulation of cadmium in kidney cortex or liver. Data were grouped into tiers based on study design and reporting of data: Tier 1, identical experimental protocols and dosage can be estimated; Tier 2, very similar or identical protocols and dosage can be estimated; Tier 3, protocols may differ and dosage can be estimated; and Tier 4, protocols may differ and dosages cannot be estimated (but concentration of cadmium in food or water is reported). Tiers were nested, such that Tier 4 contained all relevant studies; Tier 3 included data sets from Tiers 1 and 2; and Tier 2 included the data set from Tier 1. Data within Tiers 1, 2, and 3 were subjected to a linear regression analysis with dosage as the independent variable and tissue accumulation rate as the dependent variable to determine whether bioavailability of cadmium was significantly different based on medium of administration. The results of this analysis show the following: (1) In rats receiving food and drinking water ad libitum, the bioavailability of cadmium in drinking water is not significantly different (P > 0.05) from the bioavailability of cadmium in food when dosages are less than 4 mg/kg body wt/day. (2) Cadmium decreases food and water consumption; therefore, assessments of relative bioavailability should be made based on actual dosage rather than exposure levels. (3) Diet composition and status of the gastrointestinal tract are probably a more important determinant of the bioavailability of cadmium than is the exposure medium. (4) Studies of the effect of total diet composition on bioavailability of cadmium may be more relevant than are studies of the effect of the exposure medium. It is concluded from this analysis that the bioavailability of cadmium in food is not different from that in water when diet is provided ad libitum. Therefore, we recommend that distinct RfDs for cadmium in food and drinking water should not be based on the assumption that the bioavailability of cadmium in drinking water is greater than that of cadmium in food.
对已发表的、将大鼠暴露于标准饲料或饮用水中的氯化镉的研究进行了分析,以比较镉在这两种介质中的相对生物利用度。根据肾皮质或肝脏中镉的积累速率估计值来评估相对生物利用度。根据研究设计和数据报告将数据分为不同层级:第1层,可估计相同的实验方案和剂量;第2层,可估计非常相似或相同的方案和剂量;第3层,方案可能不同但可估计剂量;第4层,方案可能不同且无法估计剂量(但报告了食物或水中镉的浓度)。各层级相互嵌套,即第4层包含所有相关研究;第3层包括第1层和第2层的数据组;第2层包括第1层的数据组。对第1、2和3层内的数据进行线性回归分析,以剂量作为自变量,组织积累速率作为因变量,来确定基于给药介质镉的生物利用度是否存在显著差异。该分析结果表明:(1) 在随意进食和饮水的大鼠中,当剂量低于4 mg/kg体重/天时,饮用水中镉的生物利用度与食物中镉的生物利用度无显著差异(P>0.05)。(2) 镉会降低食物和水的摄入量;因此,应基于实际剂量而非暴露水平来评估相对生物利用度。(3) 饮食组成和胃肠道状态可能比暴露介质更重要地决定了镉的生物利用度。(4) 研究总饮食组成对镉生物利用度的影响可能比研究暴露介质的影响更具相关性。从该分析得出的结论是,当随意提供饮食时,食物中镉的生物利用度与水中镉的生物利用度没有差异。因此,我们建议,不应基于饮用水中镉的生物利用度大于食物中镉的生物利用度这一假设来设定食物和饮用水中镉的不同参考剂量。